Risk Factors for Severe Disease Among Children Hospitalized With Respiratory Syncytial Virus.

ABSTRACT:

Importance

A resurgence of respiratory syncytial virus (RSV)-associated acute respiratory tract infection (ARI) was observed in 2022 and 2023 after the COVID-19 pandemic. Changes in the demographic characteristics, disease severity, and outcomes of patients were observed, which could impact the identification of risk groups for interventions aimed at reducing the severity of RSV disease.

Objectives

To identify factors associated with severe clinical outcomes among children hospitalized with RSV-associated ARIs in 2022 and 2023.

Design, setting, and participants

This observational cohort study, conducted at 2 large, Canadian, tertiary-level pediatric hospitals, comprised all 709 cases of RSV-associated ARI among children younger than 18 years who were admitted to the h

SUBMITTER: Kirolos N 

PROVIDER: S-EPMC11992603 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature